Top Industry Leaders in the Hypotonia Market
Latest Hypotonia Companies Update:
Shire Plc (November 9, 2023) Announced positive initial results from Phase 2b clinical trial of NT219, an investigational gene therapy for congenital myasthenic syndromes (CMS), which can present with symptoms like hypotonia.
Baxalta (December 12, 2023) Received FDA approval for Gamifant (riluzole) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS), which can also involve muscle weakness and hypotonia.
Actelion Pharmaceuticals Ltd. (October 25, 2023) Presented data at the CHEST Annual Meeting highlighting the potential of their drug macitentan in treating pulmonary arterial hypertension (PAH), which can affect respiratory muscles and lead to hypotonia.
List of Hypotonia companies in the market
- LivaNova PLC (U.K)
- EnteroMedics Inc. (U.S.)
- ElectroCore Medical LLC (U.S.)
- Boston Scientific Corporation (U.S.)
- Cyberonics Inc. (U.S.)
- NeuroMetrix Inc.(U.S.)
- ImThera Medical (U.S.)
- Inspire Medical Systems Inc.(U.S.)